MAOB and Parkinson disease: It is likely that in the mLPS model, the increase of MAO-B activity secondary to the p38 MAPK pathway, which plays a role in PD pathogenesis [84], could increase the amount of MPP+ generated, effectively increasing the neurotoxin dose.